{"organizations": [], "uuid": "29f4b2acbea7fdcd01a0851fb8b8402d7c24fd26", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-feb-15-idUSL8N1Q47D3", "country": "US", "domain_rank": 408, "title": "Swiss stocks - Factors to watch on Feb 15", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-15T13:38:00.000+02:00", "replies_count": 0, "uuid": "29f4b2acbea7fdcd01a0851fb8b8402d7c24fd26"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/markets-swiss-stocks/swiss-stocks-factors-to-watch-on-feb-15-idUSL8N1Q47D3", "ord_in_thread": 0, "title": "Swiss stocks - Factors to watch on Feb 15", "locations": [], "entities": {"persons": [{"name": "julius baer", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}, {"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "chemchina", "sentiment": "none"}, {"name": "st galler kantonalbank ag", "sentiment": "none"}, {"name": "zurich insurance group", "sentiment": "none"}, {"name": "syngenta", "sentiment": "none"}, {"name": "addex therapeutics", "sentiment": "none"}, {"name": "nestle", "sentiment": "none"}, {"name": "straumann holding ag", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "ZURICH, Feb 15 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent higher at 8,910 points on Thursday, according to premarket indications by bank Julius Baer .\nHere are some of the main factors that may affect Swiss stocks.\nNESTLE The company said it expects organic sales to grow 2-4 percent this year, after they rose a mere 2.4 percent in 2017, their weakest gain in more than two decades, and a goodwill impairment on its skin health business hit net profit.\nSYNGENTA The ChemChina unit reports 2017 results\nCOMPANY STATEMENTS * Zurich Insurance Group said it has successfully placed $500 million of notes, which will mature in October 2048.\n* Straumann Holding AG expects 2018 EBIT margin to remain stable\n* St Galler Kantonalbank AG - FY consolidated profit increased by 6.8 percent, higher dividend\n* Addex Therapeutics said it was launching a 40 million Swiss franc capital increase.â€‹\nECONOMY Reporting by Zurich newsroom\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-15T13:38:00.000+02:00", "crawled": "2018-02-15T10:31:54.003+02:00", "highlightTitle": ""}